MAP2K7 and breast carcinoma: In this study, FAM53A inhibited proliferation, migration, and invasion by inhibiting MEK/ERK signaling in p53 wild-type cells, while in p53 negative breast cancer cells, FAM53A activated MEK/ERK signaling, promoting these behaviors.